NASHUA, N.H., March 02, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it is ...
Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA "iCAD is committed to developing the most comprehensive, ...
Company’s third generation AI solution offers significant improvement in algorithm specificity performance and faster processing compared to previous versions of the software Deep learning technology ...
NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported strong adoption of its latest ...
Greetings and welcome to the iCAD Incorporated Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode, and a question-and-answer session ...
NASHUA, N.H. - iCAD, Inc. (NASDAQ: NASDAQ:ICAD), a company specializing in AI-powered cancer detection solutions, announced today the FDA clearance of ProFound Detection Version 4.0 for Digital Breast ...
CHICAGO--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, ...
Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA CHICAGO--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) ,an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results